Literature DB >> 21463873

Two McLeod patients with novel mutations in XK.

Patrycja M Dubielecka1, Nelson Hwynn, Cenk Sengun, Soohee Lee, Christine Lomas-Francis, Carlos Singer, Hubert H Fernandez, Ruth H Walker.   

Abstract

McLeod syndrome (MLS) is a rare, X-linked, late-onset, disease involving hematological, brain, and neuromuscular systems, caused by mutations in XK that result in either defective XK or complete loss of XK protein. Acanthocytosis of erythrocytes is a typical feature. We report novel mutations in two patients who exhibited typical clinical characteristics of MLS. The coding and flanking intronic regions of XK were amplified by PCR, sequenced, and compared with the normal XK sequence. XK protein, and its complexed partner protein, Kell, were assessed by Western blot analysis. Patient 1 was found to have a single base insertion, 605insA at 175Ile creating a frame shift within the coding sequence of XK. Patient 2 had a single base substitution in the 3' splice sequence of intron 2 (IVS2-2a>g). In both cases mutations resulted in the absence of XK protein.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21463873      PMCID: PMC3337778          DOI: 10.1016/j.jns.2011.02.028

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  30 in total

Review 1.  The Kell blood group system: Kell and XK membrane proteins.

Authors:  S Lee; D Russo; C M Redman
Journal:  Semin Hematol       Date:  2000-04       Impact factor: 3.851

2.  Point mutations causing the McLeod phenotype.

Authors:  David C W Russo; Soohee Lee; Marion E Reid; Colvin M Redman
Journal:  Transfusion       Date:  2002-03       Impact factor: 3.157

3.  A rapid procedure for extracting genomic DNA from leukocytes.

Authors:  S W John; G Weitzner; R Rozen; C R Scriver
Journal:  Nucleic Acids Res       Date:  1991-01-25       Impact factor: 16.971

Review 4.  A reappraisal of non-consensus mRNA splice sites.

Authors:  I J Jackson
Journal:  Nucleic Acids Res       Date:  1991-07-25       Impact factor: 16.971

Review 5.  Preparation and properties of human erythrocyte ghosts.

Authors:  G Schwoch; H Passow
Journal:  Mol Cell Biochem       Date:  1973-12-15       Impact factor: 3.396

6.  McLeod syndrome: a novel mutation, predominant psychiatric manifestations, and distinct striatal imaging findings.

Authors:  H H Jung; M Hergersberg; S Kneifel; H Alkadhi; R Schiess; M Weigell-Weber; G Daniels; S Kollias; K Hess
Journal:  Ann Neurol       Date:  2001-03       Impact factor: 10.422

7.  McLeod neuroacanthocytosis: genotype and phenotype.

Authors:  A Danek; J P Rubio; L Rampoldi; M Ho; C Dobson-Stone; F Tison; W A Symmans; M Oechsner; W Kalckreuth; J M Watt; A J Corbett; H H Hamdalla; A G Marshall; I Sutton; M T Dotti; A Malandrini; R H Walker; G Daniels; A P Monaco
Journal:  Ann Neurol       Date:  2001-12       Impact factor: 10.422

8.  Evolution of striatal degeneration in McLeod syndrome.

Authors:  P O Valko; J Hänggi; M Meyer; H H Jung
Journal:  Eur J Neurol       Date:  2009-11-24       Impact factor: 6.089

9.  Benign X-linked myopathy with acanthocytes (McLeod syndrome). Its relationship to X-linked muscular dystrophy.

Authors:  M Swash; M S Schwartz; N D Carter; R Heath; M Leak; K L Rogers
Journal:  Brain       Date:  1983-09       Impact factor: 13.501

10.  Fine mapping of the McLeod locus (XK) to a 150-380-kb region in Xp21.

Authors:  M F Ho; A P Monaco; L A Blonden; G J van Ommen; N A Affara; M A Ferguson-Smith; H Lehrach
Journal:  Am J Hum Genet       Date:  1992-02       Impact factor: 11.025

View more
  2 in total

1.  Molecular Basis of KELnull Phenotype in Brazilians.

Authors:  Edmir Boturão-Neto; Mihoko Yamamoto; Akemi Kuroda Chiba; Elisa Yuriko Sugano Kimura; Maria do Carmo Valgueiro Costa de Oliveira; Cláudia Lumack do Monte Barretto; Mércia Maria Alves Nunes; Sérgio Roberto Lopes Albuquerque; Marcos Daniel de Deus Santos; José Orlando Bordin
Journal:  Transfus Med Hemother       Date:  2014-12-19       Impact factor: 3.747

2.  Does aberrant membrane transport contribute to poor outcome in adult acute myeloid leukemia?

Authors:  Alexandre Chigaev
Journal:  Front Pharmacol       Date:  2015-07-02       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.